Systemic sclerosis & Raynaud's
Patient and Physician Global Assessments of Disease Status in Systemic Sclerosis
Authors' conclusion
Marked heterogeneity was found in the wording and measurement scales of the global assessments applied in RCTs. These instruments were not developed using rigorous methodology and have not been fully validated.
Study context
- Population
- Randomized Controlled Trials (RCTs) of SSc using PtGA and PhGA
- Outcome
- Formats, wording and clinimetric properties of PtGA and PhGA in SSc RCTs
Methodological detailscomprehensive
- Comprehensive
Main finding
As reported in the abstract
- Marked heterogeneity in the wording and measurement scales of the global assessments applied in RCTs
- Instruments not developed using rigorous methodology and not fully validated
Original publication
Patient and Physician Global Assessments of Disease Status in Systemic Sclerosis. Arthritis Care Res (Hoboken). Published 6 January 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →